4/A//SEC Filing
Salkind Gene 4/A
Accession 0001683168-23-007786
CIK 0001084267other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 2:40 PM ET
Size
7.4 KB
Accession
0001683168-23-007786
Insider Transaction Report
Form 4/AAmended
Salkind Gene
Director10% Owner
Transactions
- Award
Common Stock
2023-10-06$0.65/sh+150,000$97,500→ 448,535 total - Award
Common Stock
2023-10-06→ 524,671 totalExercise: $0.70From: 2023-10-06Exp: 2023-11-30→ Common Stock (428,571 underlying)
Footnotes (3)
- [F1]The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee.
- [F2]The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023.
- [F3]Not applicable.
Documents
Issuer
Mobiquity Technologies, Inc.
CIK 0001084267
Entity typeother
Related Parties
1- filerCIK 0001592481
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 2:40 PM ET
- Size
- 7.4 KB